Centenary Institute > News > ABC News – Prostate cancer research breakthrough from Sydney’s Centenary Institute ABC News – Prostate cancer research breakthrough from Sydney’s Centenary Institute 14 May, 2015 News Type Media release Recent Stories Research to unlock the secrets of muscle loss in ageing The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap. News Type: Media release Date 28 Sep 2023 New treatment offers hope for advanced liver cancer Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide. News Type: Media release Date 26 Sep 2023 Meet Dr Bobby Boumelhem Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges. News Type: Profiles Date 22 Sep 2023 Cancer drug for COVID-19 Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients. News Type: Research News Date 19 Sep 2023
Research to unlock the secrets of muscle loss in ageing The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap. News Type: Media release Date 28 Sep 2023
New treatment offers hope for advanced liver cancer Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide. News Type: Media release Date 26 Sep 2023
Meet Dr Bobby Boumelhem Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges. News Type: Profiles Date 22 Sep 2023
Cancer drug for COVID-19 Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients. News Type: Research News Date 19 Sep 2023